Revati Tatake, Global head of Pharma and Competitive Intelligence, GlobalData, speaks about the latest clinical trial, drug development and licensing trends from China at the Outsourcing in Clinical Trials West Coast 2026 conference. Image credit: Arena International China’s rise as a source of innovative drugs is being driven by clinical trial environment that is proving…
Genomic sequencing has helped Hong Kong identify the right treatments for cancer patients more quickly, according to an expert who also suggested that the city could be a “super-linker” between mainland China and the rest of the world in drug development. Aya El Helali, a clinician-scientist in medical oncology at the University of Hong Kong,…
The time taken to approve clinical trials in the UK has dropped from an average of 91 days to just 41 days thanks to AI and other technology platforms, according to new findings published in the British Journal of Clinical Pharmacology (BJCP). Shorter waiting times follow “major reforms” backed by new digital platforms and AI…